Christopher Eide

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Ji-Ann Lee

Adjunct Assistant Professor

University of California, Los Angeles

UNITED STATES

View details

Theodore P. Braun

Oregon Health & Science University

UNITED STATES

View details

Shannon McWeeney

Professor and Vice Chair

Oregon Health & Science University

UNITED STATES

View details

Bill Chang

Professor

OHSU

UNITED STATES

View details

Guanming Wu

Oregon Health & Science University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Eide

Research Interests

Explore related searches

Contact this professor

Articles (11)

Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia

Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy

Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations

NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia

NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2<sup>V617F</sup>-positive myeloproliferative neoplasm cells

Response and Resistance to BCR-ABL1-Targeted Therapies

Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia

Collaborators (5)

Ji-Ann Lee

Theodore P. Braun

Shannon McWeeney

Bill Chang

Guanming Wu

Make your next move.